Mesenchymal stem cell therapy and acute graft-versus-host disease: a review. - Wikidata - wikimedia - TriplyDB

Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.

Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.

http://www.wikidata.org/entity/Q34294935

about

The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy Mitochondrial DNA Hypomethylation Is a Biomarker Associated with Induced Senescence in Human Fetal Heart Mesenchymal Stem Cells.Concise Review: Mesenchymal Stem Cell Therapy for Pediatric Disease: Perspectives on Success and Potential Improvements.Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target.Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation Donor mesenchymal stem cell-derived neural-like cells transdifferentiate into myelin-forming cells and promote axon regeneration in rat spinal cord transection.Comparison of biological characteristics of mesenchymal stem cells derived from maternal-origin placenta and Wharton's jelly.The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter I: current practice and remaining unmet medical needs.Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting.The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies.Reconstruction and validation of a constraint-based metabolic network model for bone marrow-derived mesenchymal stem cells.The immunosuppressive capacity of human mesenchymal stromal cells derived from amnion and bone marrow.Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid.Therapeutic potential of mesenchymal stromal cells for hypoxic ischemic encephalopathy: A systematic review and meta-analysis of preclinical studies.A simple protocol for transfecting human mesenchymal stem cells.Therapeutic effects of Wharton jelly-derived mesenchymal stem cells on rat abortion models.Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease?Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger's disease).The effects of bone marrow-derived mesenchymal stem cells on ovalbumin-induced allergic asthma and cytokine responses in mice.Dual Preconditioning: A Novel Strategy to Withstand Mesenchymal Stem Cells against Harsh Microenvironments Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering

P2860

Q26775933-61EF5CCA-6603-44F9-B62F-FD4B7D260ECD Q29994669-03A15B24-86C2-4268-9A28-05A7A7148C30 Q33581843-1247C840-4444-47CB-BADA-88CF1DEDB274 Q33722466-52BB457C-A4EE-47F5-9327-A632C50489E9 Q33774610-6ABC6574-C111-4F33-B910-71350979560C Q35586614-E6B8C7E8-9AAB-4FF9-B6C4-50E65B06D7C5 Q35642341-9615F8CB-5541-4ACF-95E4-6CAE7BE37DB0 Q36321598-4B383977-9E73-4261-8433-1D27B2CE3D23 Q38453666-2FA86E06-1AF3-4440-B8E3-2AB68028AAC0 Q38775114-811D833B-8004-4290-B755-E00170EF6ACD Q39012031-A29CFFEC-3810-4E19-A661-B474327E2E30 Q40778167-4DACE539-B4CA-442E-9D2B-AA944A610546 Q41682785-6E6E7F98-A78C-41C5-9324-5247A71EF79E Q42152726-11096150-CBA3-4B0C-9F60-B2BC92C338B6 Q47102184-F34730E3-1FED-478F-B91E-1CCD9F519821 Q47552051-6A23669F-7E57-4641-9247-1F47E3B0758C Q50213447-D98D3E68-DD29-4CE9-9E6F-8E232AD5F982 Q52763883-749D07B1-2010-4AB1-8BA2-4B6F0E3FC084 Q55128876-177421C1-1F54-4034-B655-0C1D2857A4DE Q55397763-8A600C95-3FA9-4842-BA11-D44D139C22ED Q57136159-2DA6C5B1-19A6-4E43-B09B-F6F52081B85D Q57174410-3239B1A9-BC21-4250-8865-59CC9C193A88 Q58766184-779A4927-7B69-4737-9533-2BC04B5AECE8

P2860

Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.

http://www.wikidata.org/entity/Q34294935

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.

@ast

Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.

@en

Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.

@nl

type

label

Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.

@ast

Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.

@en

Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.

@nl

prefLabel

Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.

@ast

Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.

@en

Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.

@nl

P1433

Q34294935-6487C8FF-8D3F-4FFB-8CD9-4A0997B46ED6

P1476

Q34294935-758E30AA-3780-4359-9548-537ED698B1F8

P2093

Q34294935-05A085BD-7C43-4198-97D8-80EB27FBFA9C

Q34294935-1A0AA682-3B6E-4B08-AAEF-011FED027598

Q34294935-3CC3DFBD-7806-4B38-BE8D-2D23E875923B

Q34294935-B8A3B4E1-E23D-435C-926B-A882583A1289

Q34294935-B97766E0-EE10-4B77-904D-A1F2ABE3F6CF

Q34294935-C8ABD531-F071-4B95-A093-3BA25972FDBF

Q34294935-E8E2732A-94D9-41DE-BAB4-D11FBCE1B5BB

P2860

Q34294935-0147A743-5869-438D-A4A2-62D982B3EED1

Q34294935-021F4D98-3806-439B-A900-C2A8373A33D9

Q34294935-023C4240-3E79-479C-9E91-ED1F25BF30BB

Q34294935-02F78E09-C328-490D-9704-280FF8681E7C

Q34294935-0B3077D3-DE67-4873-93CC-B5F14AC0D172

Q34294935-0BAF59BA-E6F5-4515-9786-BE68BB9D2FB3

Q34294935-0D02EA96-7CBF-4249-9E2D-E3F3DECCD81B

Q34294935-0D398AAE-65DF-4DF8-9B40-4EB303CF8948

Q34294935-0D4D7FDF-B91C-43CA-93FA-C752B4EAB042

Q34294935-0F219ABD-78B6-4853-B09D-92F26BB6F198

P2888

Q34294935-6EC0CD41-10E5-4156-B9E5-3739785EA9A3

P304

Q34294935-4683DB7D-4829-4F5F-B3CA-49A4A1C800BA

P31

Q34294935-A4A3CC7F-E844-408F-8AA1-F66D8A7E2E66

Q34294935-E8BE598A-B2B7-4C69-96CE-53DCDDFA8C1D

P356

Q34294935-64F22E33-3A36-41F4-9AAF-9693EF07F91F

P433

Q34294935-63FF7C01-2DBC-40C8-9A0E-C6A29C0BABB9

P478

Q34294935-591E0C32-BAFD-4009-AD9C-BD8FCC4913BC

P50

Q34294935-BDB52775-1F27-489E-A574-70B104C76B9D

P577

Q34294935-193734D6-9751-4C51-9671-CB2BA1F79C89

Q34294935-614E8EE2-1EE8-4294-BA33-F4258FC8E40B

P5875

Q34294935-057974A3-8239-4C12-B845-AEA8A062D58C

P6179

Q34294935-D36A0A64-B93B-4B36-B39A-A148BE63F8BC

P698

Q34294935-064B45FC-7EC0-46D8-9F22-3D1F8C70DB3C

P921

Q34294935-4BF179DF-6CDE-49E0-8BD8-57DEC76C10D2

Q34294935-8DD00CE0-172D-4A15-BBC1-85F0B7D21435

P932

Q34294935-C4C45CD8-BE6B-47FD-AB8E-A5F18D6A4ED4

P356

S13577-014-0095-X

P1433

P1476

Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.

@en

P2093

Alvaro Macedo Laureano

http://www.w3.org/2001/XMLSchema#string

Ana Paula Alegretti

http://www.w3.org/2001/XMLSchema#string

Annelise Pezzi

http://www.w3.org/2001/XMLSchema#string

Bruna Amorin

http://www.w3.org/2001/XMLSchema#string

Lucia Silla

http://www.w3.org/2001/XMLSchema#string

Maria Aparecida Lima da Silva

http://www.w3.org/2001/XMLSchema#string

Vanessa Valim

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical applications of mesenchymal stem cells

Human T regulatory cell therapy: take a billion or so and call me in the morning

Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells

Novel treatment concepts for graft-versus-host disease

Immunogenicity of Human Mesenchymal Stem Cells in HLA-Class I-Restricted T-Cell Responses Against Viral or Tumor-Associated Antigens

Embryonic stem cell lines derived from human blastocysts

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Dendritic cells in the T-cell areas of lymphoid organs

Human mesenchymal stem cells modulate allogeneic immune cell responses

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

P2888

s13577-014-0095-x

P304

137-150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13577-014-0095-X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262979629

http://www.w3.org/2001/XMLSchema#string

P6179

1021639432

http://www.w3.org/2001/XMLSchema#string

P698

24903975

http://www.w3.org/2001/XMLSchema#string

P921

mesenchymal stem cells

P932

4186969

http://www.w3.org/2001/XMLSchema#string